首页 > 用药指导 > 文章详情

Baricitinib(巴瑞替尼)艾乐明有哪些禁忌

发布时间:2025-05-03 14:39:14 阅读:1415 来源:问药网
分享至

分享到微信朋友圈

×
Scan me!

打开微信,点击底部的“发现”,

使用“扫一扫”即可将网页分享至朋友圈。

巴瑞替尼片

巴瑞替尼片 生产厂家:孟加拉伊思达(Incepta)制药有限公司 功能主治:JAK1/2抑制剂,用于多种炎症性疾病和自身免疫性疾病 用法用量:用法用量  1、类风湿性关节炎  OLUMIANT的推荐剂量为每日1次口服2mg,餐前餐后都可。  OLUMIANT可以单独使用,也可以与甲氨蝶呤或其他非生物dmard联合使用。  2、COVID-19(新冠病毒)  成人OLUMIANT的推荐剂量为每日一次口服4mg,餐前餐后都可,持续14天或直到出院,以先发生者为准。  3、斑秃  OLUMIANT的推荐剂量是2mg,每天一次口服,餐前餐后都可。  如果对治疗的反应不充分,增加到每天一次4mg。  对于几乎完全或完全的头皮脱发,睫毛或眉毛有或没有大量脱发的患者,考虑每天一次4mg治疗,伴餐前餐后都可。  一旦患者对4mg的治疗产生了充分的反应,将剂量减少到2mg,每天一次。  对于无法吞下整片药片的患者,可以考虑另一种给药方式:  1、口服分散  2、胃造口管(G管)  3、鼻胃管(NG管)或口胃管(OG管)
查看详情

Baricitinib(巴瑞替尼)艾乐明有哪些禁忌,艾乐明(Baricitinib)禁忌为:1、对巴瑞替尼或药物中的任何成分过敏的患者禁用;2、存在严重活动性感染的患者禁用;3、具有严重肝功能损害的患者禁用;4、孕妇患者禁用;5、哺乳期妇女患者禁用。

Baricitinib (巴瑞替尼) is a medication used for the treatment of rheumatoid arthritis, COVID-19, and alopecia areata. However, like any medication, there are certain contraindications and precautions that need to be considered before using it. In this article, we will explore the contraindications associated with Baricitinib and provide accurate information regarding its use.

1. Contraindications of Baricitinib:

Baricitinib is contraindicated in certain situations where its use could potentially be harmful to the patient. These contraindications include:

1.1. Hypersensitivity:

Baricitinib should not be used in individuals who have a known hypersensitivity or allergic reaction to Baricitinib or any of its components. Hypersensitivity reactions can range from mild skin rashes to severe allergic reactions, including anaphylaxis, which can be life-threatening.

1.2. Active Infections:

The use of Baricitinib is contraindicated in patients with active infections, such as tuberculosis, bacterial infections, or fungal infections. Baricitinib can suppress the immune system, which may increase the risk and severity of infections. Therefore, it should not be used during active infections.

1.3. Live Vaccinations:

Baricitinib should not be administered concurrently with live vaccines. Live vaccines contain weakened forms of the virus or bacteria that could potentially cause infection. Since Baricitinib can suppress the immune system, it may reduce the effectiveness of live vaccines and increase the risk of developing an infection.

1.4. Severe Hepatic Impairment:

Patients with severe hepatic impairment should avoid the use of Baricitinib. Baricitinib is primarily metabolized in the liver, and a compromised liver function can lead to increased exposure to the medication and potential adverse effects.

1.5. Pregnancy and Breastfeeding:

Baricitinib is not recommended during pregnancy. Adequate and well-controlled studies on the use of Baricitinib in pregnant women are lacking, and its potential risks to the fetus are uncertain. Additionally, it is unknown whether Baricitinib passes into breast milk, so caution should be exercised while using it during breastfeeding.

2. Precautions:

Apart from contraindications, there are certain precautions that should be considered when using Baricitinib. These precautions include:

2.1. Thrombosis:

Baricitinib has been associated with an increased risk of blood clots, including deep vein thrombosis (DVT) and pulmonary embolism (PE). Individuals with a history of these conditions or other risk factors for thrombosis should be closely monitored while using Baricitinib.

2.2. Gastrointestinal Perforations:

There have been rare reports of gastrointestinal perforations associated with Baricitinib. Patients with a history of gastrointestinal perforations or conditions that make them more susceptible to gastrointestinal perforations should use the medication with caution.

2.3. Laboratory Monitoring:

Regular monitoring of blood counts, liver function tests, and lipid levels is important during treatment with Baricitinib. This helps to ensure that any potential adverse effects are detected early and appropriate actions can be taken.

It is crucial to note that the information provided here is for informational purposes only. It is important to consult with a healthcare professional or pharmacist for specific advice regarding the use of Baricitinib and to discuss individual circumstances and possible contraindications or precautions.

In conclusion, Baricitinib (巴瑞替尼) is an effective medication used to treat rheumatoid arthritis, COVID-19, and alopecia areata. However, it is contraindicated in individuals with a known hypersensitivity, active infections, severe hepatic impairment, and during pregnancy and breastfeeding. Precautions should be taken in patients with a history of thrombosis, gastrointestinal perforations, and regular laboratory monitoring should be conducted. Always consult a healthcare professional before starting or changing any medication regimens, as they can provide personalized advice based on individual needs and circumstances.